Media Thread, page-12112

Can you show me where he brought it up again today? I can't see it.

Has it been said that it was the patient "has been on the clinical trial the longest"? They said it was a lower dose but I don't recall seeing/hearing about them being the first patient dosed.

If you're going to criticise him for not having the correct information, make can you direct me to where you got yours?

A level of balance and healthy scepticism isn't something you should be attacking, belittling or ignoring on a forum like this. $4. may not be correct but if his posts trigger some of our own reflection on BOTH positive and negatives then that's a good thing. Many are in love with the stock, and there has been a lot to like, but it's good to make sure we're not looking through rose-coloured glasses. IMV $4 is a reminder of that.